2BB score and signals
Nautilus Biotechnology, Inc.’s current 2BB score is 49 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 58 | Moderate |
| Momentum | 47 | Stable |
| Financial strength | 38 | Weak |
| Quality | 100 | Very Strong |
| Risk | 66 | High |
Company facts
| Headquarters | Seattle, Washington, United States |
| Founded | 2016 |
| Employees | 127 |
| 52-week range | $0.62 – $4.31 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.1275 | — | $204,000.00 |
| 2026-10-26 | — | -0.1428 | — | $204,000.00 |
| 2026-07-28 | — | -0.1377 | — | $0.00 |
| 2026-04-28 | -0.12 | -0.1479 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish